FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966454407> ?p ?o ?g. }

• W1966454407 endingPage "822" @default.
• W1966454407 startingPage "815" @default.
• W1966454407 abstract "This paper describes studies that further explore the pharmacologic activity of the 7-hydroxy catabolite of methotrexate (7-OH-MTX). A 3-hr exposure of L1210 leukemia cells to 100 μM 7-OH-MTX produced negligible suppression of cell growth despite the build-up of intracellular polyglutamyl congeners to levels 2.7 times greater than the dihydrofolate reductase (DHFR) binding capacity. There was no evidence for direct inhibition of DHFR under these conditions based upon measurements of cellular tetrahydrofolate cofactor and dihydrofolate levels, nor was there suppression of [3H]deoxyuridine incorporation into DNA or [14C]formate incorporation into purines. When the interval of exposure to 100 μM 7-OH-MTX was increased to 6 hr, cell growth was inhibited by 60% and there was mild (~50%) inhibition of purine and thymidylate biosynthesis associated with a small increase in cellular dihydrofolate and a small decline in cellular tetrahydrofolates. Consistent with weak inhibition of DHFR was the absence of significant binding of 7-OH-MTX polyglutamates to DHFR as assessed by gel filtration of cell extracts. Mild direct inhibition of purine biosynthetics by 7-OH-MTX- or MTX-polyglutamyl congeners was demonstrated based upon inhibition of [14C]formate incorporation into purines in cells pretreated with fluorodeoxyuridine so as to prevent tetrahydrofolate cofactor depletion or dihydrofolate polyglutamate build-up. Effects of a 6-hr exposure of cells to 100 μM 7-OH MTX on cell growth were reversed completely by 10 μM leucovorin; effects on cells containing comparable levels of MTX polyglutamyl congeners were unaffected by leucovorin. These studies demonstrate very weak inhibition of L1210 leukemia cell growth and purine, pyrimidine and tetrahydrofolate synthesis by the polyglutamyl congeners of 7-OH-MTX. The data suggest that effects of 7-OH-MTX polyglutamates on folate-requiring enzymes are not likely to play an important role in moderate-dose MTX regimens. However, pharmacologic activity may be expressed in high-dose MTX protocols when high blood levels of 7-OH-MTX are sustained over long intervals to the extent to which polyglutamate congeners accumulate in tumor cells and add to the much more potent inhibitory effects of MTX polyglutamates already present. Pharmacologic activity, however, would be diminished, if not completely reversed, by the concurrent administration of leucovorin." @default.
• W1966454407 created "2016-06-24" @default.
• W1966454407 creator A5021928473 @default.
• W1966454407 creator A5041681996 @default.
• W1966454407 creator A5071736781 @default.
• W1966454407 date "1989-03-01" @default.
• W1966454407 modified "2023-09-26" @default.
• W1966454407 title "Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell" @default.
• W1966454407 cites W1485678634 @default.
• W1966454407 cites W1489298252 @default.
• W1966454407 cites W1491882973 @default.
• W1966454407 cites W1514994753 @default.
• W1966454407 cites W1540897124 @default.
• W1966454407 cites W1555616833 @default.
• W1966454407 cites W1570911552 @default.
• W1966454407 cites W1594621311 @default.
• W1966454407 cites W2003098361 @default.
• W1966454407 cites W2007501368 @default.
• W1966454407 cites W2011847171 @default.
• W1966454407 cites W2013009465 @default.
• W1966454407 cites W2032440295 @default.
• W1966454407 cites W2044551530 @default.
• W1966454407 cites W2075734681 @default.
• W1966454407 cites W2084186914 @default.
• W1966454407 cites W2090763707 @default.
• W1966454407 cites W2113775994 @default.
• W1966454407 cites W2123613739 @default.
• W1966454407 doi "https://doi.org/10.1016/0006-2952(89)90236-0" @default.
• W1966454407 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2467676" @default.
• W1966454407 hasPublicationYear "1989" @default.
• W1966454407 type Work @default.
• W1966454407 sameAs 1966454407 @default.
• W1966454407 citedByCount "11" @default.
• W1966454407 countsByYear W19664544072012 @default.
• W1966454407 countsByYear W19664544072013 @default.
• W1966454407 countsByYear W19664544072014 @default.
• W1966454407 crossrefType "journal-article" @default.
• W1966454407 hasAuthorship W1966454407A5021928473 @default.
• W1966454407 hasAuthorship W1966454407A5041681996 @default.
• W1966454407 hasAuthorship W1966454407A5071736781 @default.
• W1966454407 hasConcept C109316439 @default.
• W1966454407 hasConcept C123321153 @default.
• W1966454407 hasConcept C169586020 @default.
• W1966454407 hasConcept C181199279 @default.
• W1966454407 hasConcept C185592680 @default.
• W1966454407 hasConcept C202751555 @default.
• W1966454407 hasConcept C203014093 @default.
• W1966454407 hasConcept C2776476023 @default.
• W1966454407 hasConcept C2776694085 @default.
• W1966454407 hasConcept C2778397455 @default.
• W1966454407 hasConcept C2779707156 @default.
• W1966454407 hasConcept C2780017796 @default.
• W1966454407 hasConcept C2780456651 @default.
• W1966454407 hasConcept C2781059491 @default.
• W1966454407 hasConcept C2781320022 @default.
• W1966454407 hasConcept C2781382166 @default.
• W1966454407 hasConcept C54355233 @default.
• W1966454407 hasConcept C55493867 @default.
• W1966454407 hasConcept C62112901 @default.
• W1966454407 hasConcept C79879829 @default.
• W1966454407 hasConcept C86803240 @default.
• W1966454407 hasConceptScore W1966454407C109316439 @default.
• W1966454407 hasConceptScore W1966454407C123321153 @default.
• W1966454407 hasConceptScore W1966454407C169586020 @default.
• W1966454407 hasConceptScore W1966454407C181199279 @default.
• W1966454407 hasConceptScore W1966454407C185592680 @default.
• W1966454407 hasConceptScore W1966454407C202751555 @default.
• W1966454407 hasConceptScore W1966454407C203014093 @default.
• W1966454407 hasConceptScore W1966454407C2776476023 @default.
• W1966454407 hasConceptScore W1966454407C2776694085 @default.
• W1966454407 hasConceptScore W1966454407C2778397455 @default.
• W1966454407 hasConceptScore W1966454407C2779707156 @default.
• W1966454407 hasConceptScore W1966454407C2780017796 @default.
• W1966454407 hasConceptScore W1966454407C2780456651 @default.
• W1966454407 hasConceptScore W1966454407C2781059491 @default.
• W1966454407 hasConceptScore W1966454407C2781320022 @default.
• W1966454407 hasConceptScore W1966454407C2781382166 @default.
• W1966454407 hasConceptScore W1966454407C54355233 @default.
• W1966454407 hasConceptScore W1966454407C55493867 @default.
• W1966454407 hasConceptScore W1966454407C62112901 @default.
• W1966454407 hasConceptScore W1966454407C79879829 @default.
• W1966454407 hasConceptScore W1966454407C86803240 @default.
• W1966454407 hasIssue "5" @default.
• W1966454407 hasLocation W19664544071 @default.
• W1966454407 hasLocation W19664544072 @default.
• W1966454407 hasOpenAccess W1966454407 @default.
• W1966454407 hasPrimaryLocation W19664544071 @default.
• W1966454407 hasRelatedWork W1537065657 @default.
• W1966454407 hasRelatedWork W1966454407 @default.
• W1966454407 hasRelatedWork W2085577366 @default.
• W1966454407 hasRelatedWork W2106636322 @default.
• W1966454407 hasRelatedWork W2154285369 @default.
• W1966454407 hasRelatedWork W2231300178 @default.
• W1966454407 hasRelatedWork W2471049556 @default.
• W1966454407 hasRelatedWork W288792998 @default.
• W1966454407 hasRelatedWork W338343546 @default.
• W1966454407 hasRelatedWork W4241434172 @default.
• W1966454407 hasVolume "38" @default.

• next